Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine
Antimicrobial Agents and Chemotherapy · 2023
DOI: 10.1128/aac.00010-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2023. Verfasst von Xinghong Zhao und 18 weiteren Autor:innen. Beteiligte Einrichtung: Lab for Sustainable Antimicrobials, Department of Pharmacy, Sichuan Agricultural University, Chengdu, China. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Sichuan Science and Technology Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Due to the accelerated appearance of antimicrobial-resistant (AMR) pathogens in clinical infections, new first-in-class antibiotics, operating via novel modes of action, are desperately needed. Brevicidine, a bacterial nonribosomally produced cyclic lipopeptide, has shown potent and selective antimicrobial activity against Gram-negative pathogens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Lab for Sustainable Antimicrobials, Department of Pharmacy, Sichuan Agricultural University, Chengdu, China.
- Department of Molecular Genetics, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen, Groningen, The Netherlands.
- Key Laboratory of Animal Disease and Human Health of Sichuan Province, Sichuan Agricultural University, Chengdu, China.
- State Key Laboratory of Crop Gene Exploration and Utilization in Southwest China, Sichuan Agricultural University at Wenjiang, Chengdu, Sichuan, China.
ORCID-Profile: Xinghong Zhao, Huaqiao Tang, Oscar P Kuipers
Förderung
- Sichuan Science and Technology Program
- National Natural Science Foundation of China
Zitieren
APA
Zhao, X., Zhong, X., Yang, S., Deng, K., Liu, L., Song, X., Zou, Y., Li, L., Zhou, X., Jia, R., Lin, J., Tang, H., Ye, G., Yang, J., Zhao, S., Lang, Y., Wan, H., Yin, Z., & Kuipers, O. P. (2023). Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00010-23
Vancouver
Zhao X, Zhong X, Yang S, Deng K, Liu L, Song X, et al. Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine. Antimicrobial Agents and Chemotherapy. 2023. doi:10.1128/aac.00010-23
BibTeX
@article{Zhao2023,
author = {Zhao, Xinghong and Zhong, Xinyi and Yang, Shinong and Deng, Kai and Liu, Lu and Song, Xu and Zou, Yuanfeng and Li, Lixia and Zhou, Xun and Jia, Renyong and Lin, Juchun and Tang, Huaqiao and Ye, Gang and Yang, Jianqing and Zhao, Shan and Lang, Yifei and Wan, Hongping and Yin, Zhongqiong and Kuipers, Oscar P},
title = {Elucidating the Mechanism of Action of the Gram-Negative-Pathogen-Selective Cyclic Antimicrobial Lipopeptide Brevicidine},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2023},
doi = {10.1128/aac.00010-23}
}
EUVIMED